6Y1.F INTEGRUM AB B

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.7111 EUR
Close of Nov 11, 2026
0.5880 1.03
Market cap
EUR 18.5M
P/E
-
P/B
1.15x
ROE
2.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is 6Y1.F undervalued?

Graham number

The Graham number of INTEGRUM AB B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

INTEGRUM AB B fundamental analysis

No fundamental analysis for INTEGRUM AB B yet.

INTEGRUM AB B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About INTEGRUM AB B

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technolo…

Full company profile